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ABSTRACT
Due to the characteristics of COVID-19, the epidemic develops
rapidly and overwhelms health service systems worldwide. Many
patients suffer from systemic life-threatening problems and need
to be carefully monitored in ICUs. Thus the intelligent prognosis is
in an urgent need to assist physicians to take an early intervention,
prevent the adverse outcome, and optimize the medical resource
allocation. However, in the early stage of the epidemic outbreak,
the data available for analysis is limited due to the lack of effective
diagnostic mechanisms, rarity of the cases, and privacy concerns. In
this paper, we propose a deep-learning-based approach, CovidCare,
which leverages the existing electronic medical records to enhance
the prognosis for inpatients with emerging infectious diseases. It
learns to embed the COVID-19-related medical features based on
massive existing EMR data via transfer learning. The transferred
parameters are further trained to imitate the teacher model’s repre-
sentation behavior based on knowledge distillation, which embeds
the health status more comprehensively in the source dataset. We
conduct the length of stay prediction experiments for patients on
a real-world COVID-19 dataset. The experiment results indicate
that our proposed model consistently outperforms the comparative
baseline methods. CovidCare also reveals that, 1) hs-cTnI, hs-CRP
and Platelet Counts are the most fatal biomarkers, whose abnormal
values usually indicate emergency adverse outcome. 2) Normal
values of γ -GT, AP and eGFR indicate the overall improvement of
health. The medical findings extracted by CovidCare are empiri-
cally confirmed by human experts and medical literatures.
CCS CONCEPTS
• Information systems→ Data mining; • Applied comput-
ing → Health informatics; • Computing methodologies →
Knowledge representation and reasoning.
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1 INTRODUCTION
The whole world is now facing the unprecedented crisis brought
by COVID-19. The exponential growth of COVID-19 patients has
brought massive pressure on the health systems tragically, such
as overwhelming the national health service and exhausting the
intensive care units (ICUs). It is crucially essential to personalize
prognosis for the individual patient by considering her/his specific
health condition to enable a timely and early medical intervention,
as shown in Figure 1. The accurate prediction of the remaining
length-of-stay for inpatients is critical for scheduling and optimiz-
ing limited hospital resources [14].
However, for newly-emerged infectious diseases (e.g., COVID-
19, SARS) and rare diseases, the prognosis performed by human
physicians may not meet the clinical demand, especially in rural ar-
eas and developing countries. Moreover, the precise risk prediction
requires a high level of clinical expertise and experience [28]. How-
ever, the accumulation of clinical experience is time-consuming
and difficult at the early outbreak of the new emerging infectious
disease (EID). Thus it is difficult for human physicians to compre-
hensively evaluate the health of patients and accurately identify
the key factors, especially in a situation where the deterioration of
some EIDs in the early stage is usually not evident [20]. So during
treating COVID-19, it is not so rare that physicians omit the omi-
nous signs and miss the chance of early intervention, especially
when the clinical resources are insufficient.
As a result, intelligent prognosis is in an urgent need against
EID and rare diseases. It not only can assist physicians to perform
early diagnosis, select personalized treatments, and prevent adverse
outcomes, but also optimize the allocation of medical resources and
reduce the medical cost [37]. Recently, many deep learning-based
models have been developed to enable intelligent prognosis by
analyzing electronic medical records (EMRs), including mortality
prediction [24, 25], disease diagnosis prediction [22], and patient
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Figure 1: Performing health evaluation is crucial for early
clinical intervention and medical resource management.
phenotype identification [1]. To enrich the feature extraction and
health status representation, most existing research works utilize
sophisticated modules to extract health status representations that
require a large amount of labeled training data. However, the quan-
tity of labeled clinical data available for prognosis may not be ideal
in practice in the early stage of the EID outbreak [16], due to the fol-
lowing reasons. 1) The precise diagnostic mechanism has not been
established in the early outbreak. Before introducing the nucleic
acid detectionmechanism, it is difficult to confirmwhether a patient
is really infected with COVID-19. For example, there are only 41
patients diagnosed with COVID-19 due to the lack of valid testing
methods at the early outbreak in Wuhan, [16]. 2) The disease is still
progressing for patients. The collection of enough outcomes needs
to take a long time. 3) There are serious privacy concerns about
electronic medical records, so the data-sharing mechanism for EID
across multiple hospitals worldwide usually cannot be established
timely. Therefore, the scarce labeled data will decrease the perfor-
mance of deep learning models due to the potential over-fitting.
Recently some researchers try to exploit additional information
to deal with the scarcity of clinical data. On one hand, some re-
searches encode ontology resources and structured relationships
among medical codes (e.g., diagnosis of diabetes) in the network
to enhance the representation learning. For example, GRAM [5]
and KAME [23] introduce the external well-organized ontology
information (e.g., International Classification of Diseases Codes) to
represent the medical concept as a combination of its ancestors in
the ontology via an attention mechanism. However, for the new
EIDs like COVID-19, such relationship and ontology information
are also difficult to acquire. On the other hand, some researchers
try to make full use of the existing time series data through transfer
learning. For instance, Doctor AI [4] and Gupta [12] train deep mod-
els at one hospital and transfer them to another hospital. However,
these methods can only be adapted for the same tasks with similar
clinical features between the source and target dataset. TimeNet
[12] has been trained on different non-clinical time series datasets
via an RNN autoencoder in an unsupervised manner to extract
generic features for patient phenotyping. However, the extracted
general-purpose features may not be suitable for a specific clinical
task, leading to the underperformance of the model.
Therefore, for the prognosis of EIDs with limited data, such a
research challenge remains: How to make full use of the existing EMR
data to learn the robust health status representation, when tackling
tasks with different clinical feature sets?
In this paper, we propose a novel healthcare predictive approach,
CovidCare, based on transfer learning from existing EMR data
(i.e., source dataset) to the new dataset (i.e., target dataset) with
knowledge distillation. To improve the compatibility across source
dataset and target dataset with different feature sets, CovidCare
evaluates the health status of patients mainly from the perspective
of clinical features rather than visits. The time series of each feature
is embedded separately by GRUs. When training on the target
dataset, the shared features of both datasets are specifically encoded
by a pre-trained GRU. The model with private features trained on
the source dataset is treated as a teacher network to guide the
embedding behavior of the shared features. Doing so is able to
further explore and leverage the information stored in the source
dataset. Finally, feature-wise attention is deployed to abstract the
biomarkers and adaptively identify the critical features for patients
in diverse health conditions. In summary, CovidCare contributes
to the community from the following aspects:
• We propose a transfer-learning-based medical feature embed-
ding approach, CovidCare, to perform clinical prediction for
EIDs with limited data .Multi-channel architecture is developed
to improve the compatibility across source and target datasets
with different feature sets. By jointly optimizing the prediction
loss and similarity loss, the student model with shared features
is learned to imitate the teacher model’s encoding behavior with
full features on the source dataset. We further use the feature
re-calibration module to provide the interpretability, which ex-
plicitly enhances high-risk features.
• We conduct length-of-stay prediction experiments for inpatients
with COVID-19. The results show that CovidCare significantly
and consistently outperforms the baseline approaches for all
evaluation metrics.
• CovidCare can extract valuable medical findings for COVID-19:
– Hypersensitive Cardiac Troponin, Hypersensitive C-Reactive Pro-
tein and Platelet Counts are the most fatal biomarkers, whose
abnormal values usually indicate emergency adverse outcome.
– Normal values of γ -Glutamyl Transpeptidase, Alkaline Phos-
phatase and estimated Glomerular Filtration Rate indicate the
overall improvement of health.
We invite medical practitioners to evaluate the extracted medical
knowledge and prognosis cases. Human experts positively con-
firmed the clinical significance in the aspects of early prediction,
key biomarkers extraction, and clinical resources management.
• Beyond COVID-19, we also conduct mortality risk prediction
for outpatients with end-stage renal diseases (ESRD) to verify
the applicability of CovidCare to other diseases with limited
EMR. The extensive experiments demonstrate that CovidCare
can significantly benefit the prognosis for future pandemics and
rare diseases.
2 RELATEDWORK
2.1 Prognosis for COVID-19
Outbreaks of the COVID-19 epidemic have been causing world-
wide health concerns and was officially declared a pandemic by the
World Health Organization (WHO) on March 11, 2020. Although
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the ultimate impact of COVID-19 is uncertain, it has significantly
overwhelmed health care infrastructure. All emerging viral pan-
demics can place extraordinary and sustained demands on public
health and health systems and providers of essential community ser-
vices [27]. Limited health-care resource availability will increase the
chance of being infected while waiting for treatment and also the
mortality rate [18]. This eventually leads to an increase in the sever-
ity of the pandemic. The rapidly growing imbalance between supply
and demand for medical resources in many countries presents an
inherent normative question: How can we make early and accurate
risk prediction to allocate medical resources effectively during a
pandemic?
Many COVID-related researches focus on the severity of disease
rather than the clinical outcome of mortality [8, 10, 36]. These
studies answer key clinical questions on COVID-19 evolution and
outcomes, as well as potential risk factors leading to hospital and
ICU admission. However, they cannot make individualized risk
predictions for patients. Recently, Li et al. [38] usemachine learning-
based methods such as decision tree to make risk prediction for
COVID-19 patients. However, as discussed above, many challenges,
such as data scarcity and model interpretability, have not been
adequately addressed. To optimize patient care and appropriately
deploy health care resources during this pandemic, effective and
reliable early risk prediction is still an essential and urgent problem.
2.2 Deep-Learning-Based EMR Analysis
With the prevalence of electronic healthcare information systems
in various healthcare institutions, a large amount of Electronic
Medical Records (EMR) have been accumulated over time[21, 32].
EMR is a type of multivariate time series data that records patients’
visits in hospitals (e.g., diagnoses, lab tests, as shown in Figure 2).
This provides essential healthcare information for the data-driven
clinical status prediction. Deep learning-based models have shown
the capability to performmortality prediction [9, 11, 15, 34], patients
subtyping [1], and diagnosis prediction [1, 6, 22, 26, 29, 31]. For
most of the researches, extracting advanced clinical features and
learning the compressed representation of the sparse EMR data are
fundamental procedures of clinical healthcare prediction.
EMR is longitudinally complex [7, 40]. Extracting the advanced
clinical representation would introduce more parameters into the
model, making the model more complex and hard to train. For EIDs
and some rare diseases, the quantity of labeled data is much less,
which can not support a model to be trained thoroughly. In order
to deal with this issue, some researches try to introduce additional
information about the data.
On one hand, GRAM [5] and KAME [23] incorporate the external
medical information (e.g., ontologies of the medical codes), which
makes the model to be trained more sufficiently. They exploit med-
ical knowledge in the whole prediction process by using a given
medical ontology (i.e., knowledge graph), such as the International
Classification of Diseases (ICD), to learn the representations of med-
ical codes and obtain the embeddings of medical codes’ ancestors.
MIME [7] learns the multi-level embedding of data according to the
knowledge about the inherent EMR structure (e.g., the multi-level
relationship among medical codes). However, such external struc-
tured information and the extra knowledge about the data are often
Table 1: Notations used in CovidCare
Notation Definition
yT ,tar Groundtruth of LOS prediction at T -th admission on target dataset
yˆT ,tar Prediction result at T -th admission on source dataset
yT ,src Groundtruth of prediction at T -th admission on source dataset
yˆT ,src Prediction result at T -th admission on source dataset
Rsrc The whole source dataset
Rtar The whole target dataset
R˜tar Target dataset (only included shared features with source dataset)
ri A time series record of the i-th medical feature
fi Embedding of the i-th medical feature
f ∗i Embedding of the i-th medical feature after self-attention
s Overall representation of patient
Xtea Model/Embeddings/Parameters used in Teacher model
Xstu Model/Embeddings/Parameters used in Student model
Xtar Model/Embeddings/Parameters used in Target model
not easy to be accessed or used in the clinical practice for EIDs.
Ontology information is usually designed to handle the medical
codes. It is not suitable for dealing with numerical lab tests, which
also are essential clinical features to capture health status.
On the other hand, some researchers try to explore the existing
EMR data. Choi [4] empirically confirms that RNN models possess
great potential for transfer learning across different medical insti-
tutions. Gupta [12] trains a deep RNN to identify several patient
phenotypes on time series from MIMIC-III database, and then uses
the features extracted using that RNN to build classifiers for identi-
fying previously unseen phenotypes. However, these methods can
only be utilized for the same tasks with the same clinical feature
sets between source and target datasets. TimeNet [13] is pre-trained
on non-medical time series in an unsupervised manner and further
utilized to extract features for clinical prediction. Nevertheless, the
extracted general-purpose features may not be suitable for explor-
ing the specific clinical task, thus leading to limited performance.
3 PROBLEM FORMULATION
Many patients suffering from COVID-19 face severe life threats and
need careful health monitoring and medical treatment in ICU. Typ-
ically, some biomarkers, such as Hypersensitive C-Reactive Protein,
are recorded through the treatment trajectories, and further have
been taken into consideration for the prognosis. Accurate prediction
of health status can help with assessing the severity of illness; and
determining the value of novel treatments, interventions, and health
care policies [30]. Besides, due to the characteristics of COVID-19,
large numbers of sick people appear for treatment during peak
illness periods. Clinics and hospitals are overwhelmed. Predicting
remaining time spent in ICU (i.e., length of stay) for admission is
also vital for scheduling and hospital resource management.
Below we define the data and task studied in this work and
provide the list of notations used in CovidCare in Table 1.
Definition: Electronic Medical Records (EMR) Electronic
Medical Records (EMR) data are routinely collected patient obser-
vations from hospitals through the clinical admissions, including
discrete time-series data (e.g., medication, diagnosis) and continu-
ous multivariate data (e.g., vital signs, laboratory measurements),
as shown in Figure 2. The admissions generating N features such
as different lab test results denoted as ri ∈ RT (i = 1, 2, · · · ,N ).
Each medical feature containsT timesteps, as shown in Figure 2. As
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Figure 2: Medical features. The physician conducts the nec-
essary lab tests for the patient at each admission.
a result, such a clinical sequence can be formulated as a âĂĲlongi-
tudinal patient matrixâĂİ record , where one dimension represents
medical features and the other denotes admission timestamps [21].
Problem: Length of stay prediction The prediction problem
in this paper can be formulated as given Nr historic EMR data of
a patient, i.e., (r1, · · · , rN ), how to predict the patient’s remain-
ing time spent in ICU, yˆ (i.e., length of stay). We frame length of
stay (LOS) prediction as a classification problem with 12 classes
(discharging in 1/2/3/5/10/10+ days, suffering adverse outcome in
1/2/3/5/10/10+ days).
4 METHODOLOGY
4.1 Overview
Figure 3 shows the framework of the proposed CovidCare, which
comprises of the following procedures. The whole model training
process is shown in the Appendix, Algorithm 1.
• Multivariate time series with all features are fed into the health-
care representation learning module as a teacher model to build
the comprehensive embedding in the source dataset.
• The student model in the source dataset learns to embed the
proper health status based on features that are shared with the
target dataset, by imitating the teacher model’s embedding be-
havior.
• The learned parameters of feature embedding are transferred
to the healthcare representation learning model for the target
dataset, and further fine-tuned to perform the task-specific pre-
diction.
4.2 Healthcare Representation Learning
In this subsection, we will introduce the patient health status em-
bedding module based on ConCare [25], which is a healthcare
context representation learning method. There are three layers de-
signed in this module, which consist of the feature extracting layer,
self-attention layer, and prediction layer.
We utilized the multichannel GRU mechanism in the feature
extracting layer to capture different patterns of eachmedical feature
individually, which is also designed to improve the scalability and
compatibility of the feature-specific model transfer. Specifically,
we apply N different GRUs to embed the N medical features. Each
feature i can be described as a time series ri = (ri1, ri2, · · · , riT ),
and will be fed into the corresponding GRUi to generate feature
embedding fi : fi = GRUi (ri1, ri2, · · · , riT ). The feature embedding
matrix F = (f1, f2, · · · , fN )T.
In the self-attention layer, we employ themulti-head self-attention
mechanism to obtain information from the health context and bet-
ter understand the correlations between medical features. This
mechanism makes each feature adaptively interact with all other
features, and combine information from the related ones according
to self-attention weights. Mathematically, the self-attention weight
matrix of head i:
Ai = Softmax(
QiKTi√
dk
) (1)
where Qi = F ·WQi ,Ki = F ·WKi , and dk is the size of the row
vector of matrix Ki . And the result of feature interaction in head i:
headi = AiVi (2)
where Vi = F ·WVi . And finally, the embedding matrix F∗ after
feature interaction:
F∗ = (f ∗1 , ..., f ∗N )T = (head0 ⊕ head1 ⊕ ... ⊕ headm )WO (3)
We also utilize the attention mechanism to integrate embed-
dings of all features f ∗i into an overall representation of patient
s , and interpret the importance of medical features at the same
time. Eventually, in the prediction layer, we apply a full-connection
layer to conduct corresponding prediction tasks, and we select
cross-entropy as the loss term Lpred .
Lpred = CE(yˆT ,yT ) = −
1
B
B∑
b=1
[ybT log(yˆbT ) + (1 − ybT ) log(1 − yˆbT )]
(4)
4.3 Knowledge Distillation
Firstly, wewill introduce the feature-specific transfer learningmech-
anism. As we mentioned before, a small data volume of the dataset
may restrict a deep learning model’s training performance. If our
target task only consists of relatively few data items, it is necessary
to make use of the existing EMR dataset with a bigger data volume
to help our model training. Because the information and pattern
extracted from a bigger dataset are always more stable and general,
which is also useful to our target model.
Based on the patient health status embedding module introduced
above, we conduct feature-specific transfer learning on feature
extraction layer, since this layer mainly captures the general pattern
of medical features, which is independent of patient cohorts and
prediction tasks. Concretely, we transfer GRUs of shared features
from the source model to the target model, so that we can make
up for the shortcomings of small data volume by transfer obtained
knowledge from a bigger dataset.
However, we have not sufficiently extracted information from
our source dataset since some private features remain unused, and
it is obvious that unused features in the source dataset can also
provide sufficient significant information. In other words, with a
complete source dataset, we can capture correlations between fea-
tures more sufficiently, and thus generating a more comprehensive
representation of patients.
Therefore, we proposed a knowledge distillation method to con-
struct a more comprehensive transfer source model. We divide the
source model into two parts, teacher model and student model. The
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Figure 3: The CovidCare Framework
student model is trained on the source dataset with only shared fea-
tures (R˜src ) and will be transferred to the target model. While the
teacher model is trained on the complete dataset with all features
(Rsrc ), but only auxiliary to student model and will not be trans-
ferred. Specifically, ’Knowledge distillation’ exactly means we hope
the student model could imitate the behavior of the teacher model
to learn a more comprehensive representation of patients, just like
the teacher model does. We design an additional loss term for this,
which encourages the student model to restore the representation
learned by the teacher model.
In detail, we first train the teacher model to generate represen-
tation stea for every patient with loss term Ltea = Lpred . We
then train the student model, where the representation sstu should
perform two functions, to predict corresponding task labels, and
to imitate stea by a linear layer as much as possible. We use KL-
divergence to calculate the similarity of the two representations.
sˆtea = sstu ·Wstu (5)
Lemb = DKL(Softmax(sˆtea )| |Softmax(stea )) (6)
DKL(P | |Q) =
∑
i
Pi log( Pi
Qi
) (7)
The loss of student model (Lstu ) is described as the sum of two
parts accordingly, Lstu = Lpred + Lemb . And finally we tranfer
GRUs from student model to target model, and fine tune the target
model with target dataset(Rtar ) using loss term Ltar = Lpred .
5 EXPERIMENT
We conduct the experiment that leveraging data from PhysioNet
Source Dataset [33] to enhance the LOS prediction for COVID-
19 [38].
Table 2: Statistics of the Datasets
Dataset PhysioNet COVID-19
# of patients 40,336 375
# of admissions 1,552,210 6,120
Avg. # of admissions per patient 38.48 16.32
Max. # of admissions per patient 336 59
Min. # of admissions per patient 8 1
# of features 33 74
# of adverse outcomes 2,932 174
% of adverse outcomes 7.26% 46.40%
5.1 Data Description
5.1.1 COVID-19 target Dataset. We take the COVID-19 dataset
[38] as the target dataset and perform the LOS prediction. The med-
ical information of all patients collected between 10 January and
18 February 2020 was used for model development. The average
age of the patients was 58.83 years, and 59.7% were male. Of the
375 cases included in the subsequent analysis, 201 recovered from
COVID-19 and were discharged from the hospital, while 174 died.
Statistics of source dataset and target dataset are listed in the Ap-
pendix. Statistics of the LOS are listed in Table 5. Without loss of
generality, we perform the length of stay prediction for patients
at 10th admission in this paper. The distribution of days to the
outcome for admissions are shown in Figure 5. Medical features
recorded in COVID-19 target dataset are listed in Table 6.
5.1.2 PhysioNet Source Dataset. We take the PhysioNet Dataset [33]
as the source dataset and pre-train the medical feature embedding
based on the Sepsis prediction. This dataset is sourced from ICU
patients in two separate U.S. hospital systems. These data were
collected over the past decade with approval from the appropriate
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Table 3: Length of Stay Prediction Performance
Length of Stay Prediction Performance on COVID-19 Dataset
Methods Transfer AUPRC AUROC-Macro AUROC-Micro min(Se, P+)
GRU × 0.2146 (0.0343) 0.6636 (0.0464) 0.7325 (0.0362) 0.2608 (0.0435)
MC-GRU × 0.2603 (0.0331) 0.7702 (0.0334) 0.8044 (0.0247) 0.3038 (0.0276)
ConCare × 0.3046 (0.0312) 0.7792 (0.0214) 0.8199 (0.0186) 0.3483 (0.0114)
TimeNet
√
0.2908 (0.0325) 0.7752 (0.0299) 0.8093 (0.0229) 0.3354 (0.0356)
MC-GRUt
√
0.2946 (0.0331) 0.7761 (0.0300) 0.8155 (0.0189) 0.3413 (0.0308)
CovidCare stu
√
0.2989 (0.0342) 0.7768 (0.0160) 0.8146 (0.0130) 0.3236 (0.0231)
CovidCare
√
0.3252 (0.0457) 0.7859 (0.0202) 0.8245 (0.0230) 0.3538 (0.0246)
Institutional Review Boards. They are labeled by Sepsis-3 clinical
criteria. The cleaned dataset consists of 40,336 patients and consists
of a combination of hourly vital sign summaries (e.g., heart rate,
systolic blood pressure), laboratory values (e.g., Chloride, Glucose).
In particular, the data contained 33 clinical variables: 8 vital sign
variables and 25 laboratory variables. The statistics of the datasets
are presented in Table 2. Medical features recorded in the PhysioNet
source dataset are listed in Table 6.
5.2 Experimental Setup
5.2.1 Evaluation Preparation. Due to the limited amount of data,
5-fold cross-validation is employed on the prediction task. We do
not separate independent test data. We assess the performance
of multi-classification using the area under the receiver operat-
ing characteristic curve (AUROC-Micro/Macro), area under the
precision-recall curve (AUPRC), the minimum of precision and sen-
sitivity Min(Se, P+). Note thatMicro calculates metrics globally by
considering each element of the label indicator matrix as a label.
Macro calculates metrics for each label and find their unweighted
mean. This does not take label imbalance into account.
5.2.2 Baseline Approaches. We introduce several deep-learning-
based models as our baseline approaches without additional labeled
data or external ontology resources.
• GRU is the basic Gated Recurrent Unit network.
• MC-GRUs embeds the clinical feature via separate GRUs.
• MC-GRUst is pre-trained at the source dataset to obtain the
parameters of corresponding GRUs.
• ConCare (AAAI 2020) [25] embeds the feature sequences sepa-
rately and uses the self-attention to model dynamic features and
static baseline information.
• TimeNet (IJCAI 2018) [13] maps variable-length clinical time
series to fixed-dimensional feature vectors separately, and acts
as an off-the-shelf feature extractor. It is pre-trained on the UCR
time series Repository.
• CovidCare stu is the proposed CovidCare without knowledge
distillation from the teacher model.
5.3 Experiment Results
As is shown in Table 3 CovidCare consistently outperforms both
transfer-based and non-transfer-based baselines, demonstrating its
ability to learn a robust representation. CovidCare achieves 6.8%
relative higher AUPRC and 1.5% higher min(Se, P+) compared to
the best state-of-the-art models ConCare and TimeNet. Comparing
all the methods with and without transfer mechanism, we can tell
that utilizing preset knowledge from existing EMR can significantly
promote the prediction performance of all models, indicating the
effectiveness of the transfer learning mechanism. Moreover, we
can see that CovidCare shows a higher performance than TimeNet.
Both models employ feature-level transfer. However, our model
CovidCare executes a more adaptive and reasonable transfer, which
explains the superiority of our model’s performance. The knowl-
edge distillation mechanism makes sense as well. Compared to
the reduced CovidCarestu model, CovidCare also achieves higher
performance in terms of all metrics. This indicates that develop-
ing knowledge distillation based on leveraging existing EMR can
enhance healthcare prediction.
5.4 Implications for COVID-19
To quantitatively identify the reasonability of feature recalibration
from an overall perspective and extract useful medical knowledge,
we calculate the average importance weights of biomarkers for
patients in diverse conditions. As shown in Figure 4, some essen-
tial medical knowledge learned by CovidCare can be summarized.
Many of them have been proved or mentioned in COVID-19 related
medical literature. We also invite medical practitioners to evaluate
the findings empirically.
• Hypersensitive Cardiac Troponin has the most distinct difference
between discharging and death cases, whichmeans that CovidCare
considers it as a significant mortality risk indicator. According to
Chapman et al [2], troponin is elevated in one in five patients who
have (confirmed) COVID-19 and that the presence of elevated
troponin in COVID-19 may be associated with higher mortal-
ity risk. COVID-19 patients with elevated troponin may also be
more likely to require ventilation and develop acute respiratory
distress syndrome. For these patients, if clinicians are reluctant
to measure cardiac troponin, they may ignore the plethora of
ischaemic and non-ischaemic causes of myocardial injury related
to COVID-19, which leads to a higher mortality rate.
• γ -Glutamyl Transpeptidase (GGT) and Alkaline Phosphatase are
another two key features that CovidCare identified. They are
significant biomarkers related to liver injury. According to a re-
cent study published in the Lancet [39], they are all related to
COVID-19 patients’ health status. Liver damage in mild cases
of COVID-19 is often transient and can return to normal with-
out any special treatment. However, when severe liver damage
occurs, liver protective drugs have usually been given to such
patients. In their case studies, GGT is elevated in 30 (54%) of 56
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Figure 4: Importance of Medical Features Differentiated by CovidCare. Features marked in red are fatal indicators for pa-
tients in critical conditions, whose abnormal values indicate the emergency adverse outcome. Features marked in green are
discharging indicators, whose normal values indicate an overall improvement and soon discharging.
Table 4: Mortality Prediction Performance for ESRD
Mortality Prediction Performance
Methods Trans. AUPRC AUROC min(Se, P+)
GRU × 0.7142 (.0883) 0.8094 (.0547) 0.6668 (.0544)
MC-GRU × 0.7335 (.0757) 0.8193 (.0468) 0.6670 (.0645)
ConCare × 0.7291 (.0827) 0.8259 (.0456) 0.6784 (.0573)
TimeNet
√
0.6328 (.0310) 0.7311 (.0262) 0.5926 (.0194)
MC-GRUt
√
0.7466 (.0486) 0.8260 (.0330) 0.6963 (.0306)
CovidCare stu
√
0.7414 (.0692) 0.8263 (.0427) 0.6723 (.0523)
CovidCare
√
0.7614 (.0584) 0.8361 (.0385) 0.7046 (.0353)
patients with COVID-19 during hospitalization in their center.
They also mention that elevated alkaline phosphatase levels are
observed in one (1Âů8%) of 56 patients with COVID-19 during
hospitalization.
• estimated Glomerular Filtration Rate (eGFR), Urea and Creatinie
are kidney injury-related biomarkers, and their difference be-
tween live and death cases are also distinct. According to Cheng
et al [3], for on admission COVID-19 patients, Creatinie and Urea
are elevated in 14.4% and 13.1% of the patients, respectively. eGFR
< 60 ml/min per 1.73m2 is reported in 13.1% of patients. Com-
pared with patients with normal Creatinie, those who entered the
hospital with an elevated Creatinie are older and more severely
ill. The incidence of in-hospital death in patients with elevated
baseline serum creatinine is 33.7%, which is significantly higher
than in those with normal baseline serum creatinine (13.2%).
6 EXTENDED DATASET EVALUATION
In order to further verify the generality of CovidCare, we also con-
duct an additional experiment on end-stage renal disease (ESRD)
dataset. We take the ESRD dataset as the target dataset and perform
the mortality prediction. Currently, many people are suffered from
ESRD in the world [17, 35]. They face severe life threats and need
lifelong treatments with periodic visits to the hospitals for multifar-
ious tests (e.g., blood routine examination). The whole procedure
needs a dynamic patient health risk prediction to help patients
recover smoothly and prevent the adverse outcome, based on the
medical records collected along with the visits. The core task of
CovidCare is to learn the health status representation of the patient
and perform the healthcare prediction.
In this study, all ESRD patients who received therapy from Janu-
ary 1, 2006, to March 1, 2018, in a real-world hospital are included
to form this dataset. During and after data collection and analysis,
we did not identify individual participants as the patients’ names,
and they were replaced by patient ID. This study was approved by
the Medical Scientific Research Ethical Committee. We drop the
patients whose all entries of one feature are missing and select the
observed features in more than 60% of patients’ records. For miss-
ing values, we fill the missing front cells with the data backward
to prevent future information leakage. If the patient’s backward
record is missing, we impute it with the first front observed record
of the patient.
The cleaned dataset consists of 662 patients and 13,108 visits.
The statistics of the ESRD dataset are presented in Table 7. Medical
features recorded in the ESRD target dataset are listed in Table 8.
The mortality prediction task on ESRD datasets is defined as a
binary classification task of predicting the death of a patient in one
year.
For the binary classification task, we assess performance using
the area under the receiver operating characteristic curve (AU-
ROC), area under the precision-recall curve (AUPRC), and the mini-
mum of precision and sensitivity Min(Se, P+). According to Table 4,
CovidCare consistently outperforms other baseline approaches for
all metrics. The experiment results verify the applicability of our
proposed framework. CovidCare can not only predict LOS for new
EID, but also perform mortality prediction for ESRD, which is the
disease with limited EMR.
7 CONCLUSIONS
In this paper, we propose a transfer learning-based prognosis so-
lution, CovidCare, to perform the length of stay prediction for
patients with COVID-19. In order to embed the medical features
robustly, the model is trained to imitate the teacher model’s medical
embedding behavior via knowledge distillation. The experimental
results on the real-world COVID-19 dataset show that CovidCare
Woodstock ’20, 2020, Woodstock Liantao Ma, Xinyu Ma, Junyi Gao, Chaohe Zhang, Zhihao Yu, Xianfeng Jiao, Wenjie Ruan, Yasha Wang, Wen Tang, and Jiangtao Wang
consistently outperforms several competitive baseline methods.
More importantly, CovidCare identifies several key indicators (e.g.,
hs-cTnI, hs-CRP and Platelet Counts) for patients with critical con-
ditions, and those abnormal values indicate potential emergent
adverse outcomes. CovidCare also reveals that normal values of
γ -GT, AP and eGFR indicate the overall improvement of health
and a possible early-discharging. The medical findings extracted
by CovidCare are empirically validated and confirmed by human
experts and medical literature. We believe the proposed model,
CovidCare, will significantly benefit the intelligent prognosis for
tackling future emerging infectious diseases such as COVID-19.
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Table 6: Features Recorded in COVID-19 and PhysioNet
Dataset
Shared Features Private in PhysioNet Private in COVID-19
Hs-cTnI Heart rate γ -GT
Hemoglobin Pulse oximetry Procalcitonin
Serum chloride Temperature Albumin
Alkaline phosphatase Systolic BP HBsAg
Total bilirubin MAP Globulin
Creatinine Platelet count HsCRP
Hematocrit Diastolic BP Serum sodium
WBC Respiration rate Red blood cell count
Fibrinogen EtCO2 nucleic acid detection
Urea Excess HCO3 Monocytes
PH value FiO2 Antithrombin
Serum potassium PaCO2 Total protein
Glucose SaO2 HCV-AQ
Direct bilirubin AST Total cholesterol
HCO3- Lactic acid Lactate dehydrogenase
Calcium Magnesium HIV-AQ
aPTT Phosphate ...
Table 7: Statistics of ESRD Dataset
Statistic Value
# patients 656
# patient with diabetes 244
# patient died 261
# visit 13091
# visit in high risk 1196
# visit in low risk 10804
# visit in uncertain 1091
% female 49%
Table 8: Features Recorded in ESRD Target Dataset
Shared Features Private in ESRD
Systolic BP Sodium
Diastolic BP CO2CP
Urea Albumin
Calcium hs-CRP
Chloride Weight
Creatinine Amount
Glucose
Phosphate
Potassium
Hemoglobin
WBC Count
Algorithm 1 CovidCare (Rsrc ,Rtar )
1: Randomly initializing parameters in Teacher Model CovidCare
tea
2: while not convergence do:
3: Compute yˆT ,src , stea = CovidCaretea (Rsrc )
4: Compute Lpred = CE(yˆT ,src ,yT ,src )
5: Compute Ltea = Lpred
6: Update parameters of CovidCaretea by optimizing Ltea
using back-propagation
7: end while
8: Randomly initializing parameters in Student Model CovidCare
stu
9: while not convergence do:
10: Compute yˆT ,src , sˆtea = CovidCarestu (R˜src )
11: Compute Lpred = CE(yˆT ,src ,yT ,src ), Lemb =
DKL(Softmax(sˆtea )| |Softmax(stea ))
12: Compute Lstu = Lpred + Lemb
13: Update parameters of CovidCarestu by optimizing Lstu
using back-propagation
14: end while
15: Transfer parameters of shared GRUs from CovidCare stu to
Target Model CovidCare tar , and randomly initializing other
parameters in CovidCare tar
16: while not convergence do:
17: Compute yˆT ,tar = CovidCarestu (Rtar )
18: Compute Lpred = CE(yˆT ,tar ,yT ,tar )
19: Compute Ltar = Lpred
20: Update parameters of CovidCaretar by optimizing Ltar
using back-propagation
21: end while
Table 5: Statistics of Length of Stay for COVID-19
All Discharging Death
Avg. # of admissions per patient 16.29 16 16.7
Avg. # of LOS per patient 10.85 13.45 7.85
Avg. # of LOS per admission 8.2 9.71 6.52
and Data Mining. ACM, 2171–2180.
A APPENDIX
A.1 Experiment Environment
The experiment environment is a machine equipped with CPU: Intel
Xeon E5-2630, 256GB RAM, and GPU: Nvidia RTX8000. The code
is implemented based on Pytorch 1.5.0. To train the model, we use
Adam [19] with the batch size of 256, and the learning rate is set to
1e−3. To fairly compare different approaches, the hyper-parameters
of the baseline models are fine-tuned by the grid-searching strategy.
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Figure 5: Days to Outcome for Admissions of Patients with
COVID-19
